Bristol-Myers Squibb Company

Date	Subject
06/26/97
	Two Drugs Better Than One For Treating Children With Symptomatic HIV
06/12/97
	Didanosine Better Than Zidovudine In HIV-Infected Kids -- Study
06/09/97
	Skin Patch Formulation Of Anti-Anxiety Drug May Help Hyperactive Kids
05/23/97
	LIPID Study Closed Early, Data Favor Pravastatin in CHD
05/20/97
	Serzone Is Associated with Greater Improvement Of Sleep Quality -- Study
05/12/97
	Vagistat-1, First One-Dose OTC Yeast Infection Treatment Now Available
05/08/97
	BMS to Acquire Mexico’s Biggest Milk-Based Nutritional Supplement
04/24/97
	FDA Clears New Labeling for Pravachol; Less Frequent Liver Testing Needed
04/18/97
	Ian Stuart Named President, Mead Johnson Nutritionals
04/08/97
	New Two-Drug HIV Therapy Shown to Be Safe, Effective
02/18/97
	Phase III Program On Trandermal Buspirone Patch Initiated
02/12/97
	OTC VAGISTAT-1 Treatment for Vaginal Yeast Infections Cleared by FDA
01/17/97
	Voluntary Limited Recall of Ovcon 35 by Bristol-Myers Squibb
01/16/97
	Novel Chronic Depression Treatment Study Evaluates Serzone
	ZERIT, an Important New Option for Treating HIV-Infected Children
01/02/97
	Zerit for HIV/AIDS to be Reimbursed by Quebec Government
12/19/96
	Zerit for HIV/AIDS to be Reimbursed by Ontario Government
12/12/96
	Broad-Spectrum Antifungal Licensed by Bristol-Myers Squibb
12/05/96
	First Multi-Center Study On Hard-To-Treat Acute Otitis Media
12/03/96
	Agreement With NCI for Extended Collaborative Research of Taxol
11/11/96
	Women's Substudy Of the Cholesterol and Recurrent Events (CARE) Trial
10/02/96
	Pravachol Reduces Risk of Recurrent Heart Attack and Death
07/08/96
	Pravachol Cleared to Help Prevent First Heart Attack and Reduce Death
06/10/96
	Glucophage Selected in Major Diabetes Prevention Trial
05/20/96
	Taxol Combination Therapy Highly Active for Advanced Ovarian Cancer
05/15/96
	Bristol-Myers Squibb Supports Three Major Clinical Studies For Taxol®
04/16/96
	Pravachol Cleared by FDA to Reduce the Risk of Heart Attacks
04/01/96
	Ceretec New Alzheimer's Diagnostic Agent Now Available
02/29/96
	FDA Unanimously Recommends Approval of Videx(r) for HIV/AIDS
02/28/96
	Videx Prolongs Lives and Dramatically Delays Progression of AIDS
02/12/96
	Bristol-Myers Squibb Acquires Exclusive Rights to the COMPASS System
01/17/96
	New Collaboration in Developing Drug for Parkinson's Disease
01/05/96
	Zerit Cleared Under FDA Accelerated Approval Regulations
11/15/95
	Landmark Study: Pravastatin Reduces Risk of Heart Attack and Saves Lives
10/02/95
	51 Million Americans Affected at a Cost of $160 Billion
09/06/95
	Routine Use of Cholesterol-Lowering Drug Improves Outcomes for Heart Transplant Recipients
08/01/95
	Expanded labelling requested for Zerit

More "Top of the News" stories